Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dotarem PK/Safety in Pediatric Subjects <2 Years
NCT02411201Phase 4Completed
- Sponsor
- Guerbet
- Start
- Mar 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of gadoterate meglumine, sponsored by Guerbet. Started Mar 2015; status: completed.
02
Drugs
gadoterate meglumine
Beyond the preview
Go deeper on NCT02411201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02411201.